ACL TOP CTS; PN 0000280020 Bench top, fully automated, random access analyzer designed specifi...
FDA Device Recall #Z-2246-2013 — Class II — July 19, 2013
Recall Summary
| Recall Number | Z-2246-2013 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 19, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Instrumentation Laboratory Co. |
| Location | Bedford, MA |
| Product Type | Devices |
| Quantity | 486 |
Product Description
ACL TOP CTS; PN 0000280020 Bench top, fully automated, random access analyzer designed specifically for in vitro diagnostic clinical use in the hemostasis laboratory for coagulation and/or fibrinolysis testing in the assessment of thrombosis and/or hemostasis. The systems provide results for both direct hemostasis measurements and calculated parameters.
Reason for Recall
Potential carryover issue that can can cause shortened APTT clotting times on the instrument.
Distribution Pattern
Worldwide Distribution - USA including AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, and WV. Internationally to Canada, Argentina, Australia, Austria, Belarus, Belgium, Brazil, Brunei, Chile, China, Colombia, Costa Rica, Czech Republic, Denmark, Dubai, Finland, France, Germany, Great Britian, Greece, Guatemala, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Luthuania, Luxembourg, Malaysia, Mexico, Netherlands, New Zealand, Norway, Panama, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey, Uruguay, Venezuela, and Viet Nam.
Lot / Code Information
Start SN and Date: 06020101, Feb 2006; End SN and Date: 10080662, Aug 2010
Other Recalls from Instrumentation Laboratory Co.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2487-2019 | Class II | ROTEM ex-tem Rest of the world part No: 503-05... | Jul 23, 2019 |
| Z-2486-2019 | Class II | ROTEM ex-tem Canada Part No: 503-05-CA | Jul 23, 2019 |
| Z-2485-2019 | Class II | ROTEM ex-tem; US Part No: 503-05-US | Jul 23, 2019 |
| Z-0077-2019 | Class II | Hemosll ReadiPlasTin (10 mL Size), Part Number ... | Aug 1, 2018 |
| Z-0895-2018 | Class II | Hemosll ReadiPlasTin (20 ml Size), Part Number ... | Aug 2, 2017 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.